iBio posts $33M net loss in fiscal 2026 as R&D spending surges Aug 28, 2026 07:02AM
Werewolf Therapeutics to merge with Ambros in $150M private placement Aug 21, 2026 08:00AM
Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P. Aug 14, 2026 06:11AM
Form SCHEDULE 13G/A TXNM ENERGY INC Filed by: BALYASNY ASSET MANAGEMENT L.P. Aug 14, 2026 06:11AM
Form SCHEDULE 13G/A Talkspace, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P. Aug 14, 2026 06:10AM
View Older Stories

Aug 14, 2026 06:10AM Form SCHEDULE 13G SkyWater Technology, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:10AM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:10AM Form SCHEDULE 13G/A Rezolute, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:10AM Form SCHEDULE 13G/A Rallybio Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:10AM Form SCHEDULE 13G Sagimet Biosciences Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G Research Alliance Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G/A Nasus Pharma Ltd Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G Quince Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G Neurogene Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G/A Minerva Neurosciences, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G JATT II Acquisition Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G/A Korro Bio, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G/A Contineum Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G Cyclerion Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G/A Helix Acquisition Corp. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G/A CRESCENT BIOPHARMA, INC. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:09AM Form SCHEDULE 13G Cellectar Biosciences, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 14, 2026 06:08AM Form SCHEDULE 13G/A Camp4 Therapeutics Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
Aug 4, 2026 07:00AM Camp4 Therapeutics closes second tranche of $100M private placement
Aug 3, 2026 09:00AM Obsidian Therapeutics completes Galera merger, raises $350M
Jul 27, 2026 07:02AM Camp4 Therapeutics gets Australian clearance for SYNGAP1 drug trial
Jul 16, 2026 05:16PM Jasper Therapeutics completes Kira acquisition, raises $132M
Jul 14, 2026 06:01AM NextCure and Avere to merge, targeting oral IL-23 therapy
Jun 23, 2026 07:30AM Boundless Bio agrees to merge with Serapha Bio in all-stock deal
May 20, 2026 09:00AM Research Alliance Corporation III prices $75 million IPO at $10 per share
May 18, 2026 09:27AM Quince acquires Orphai for LAM-001 drug, raises up to $187 million
May 15, 2026 06:41AM Form SCHEDULE 13G Contineum Therapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:39AM Form SCHEDULE 13G/A Enhabit, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:39AM Form SCHEDULE 13G/A Opus Genetics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:36AM Form SCHEDULE 13G Helix Acquisition Corp. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:33AM Form SCHEDULE 13G Rezolute, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:32AM Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:31AM Form SCHEDULE 13G CRESCENT BIOPHARMA, INC. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:30AM Form SCHEDULE 13G Camp4 Therapeutics Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:29AM Form SCHEDULE 13G SAB Biotherapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:24AM Form SCHEDULE 13G/A Lexeo Therapeutics, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:22AM Form SCHEDULE 13G Talkspace, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:22AM Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:22AM Form SCHEDULE 13G Rallybio Corp Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:22AM Form SCHEDULE 13G/A Verastem, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:22AM Form SCHEDULE 13G Nasus Pharma Ltd Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:21AM Form SCHEDULE 13G/A Minerva Neurosciences, Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:21AM Form SCHEDULE 13G TXNM ENERGY INC Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 06:20AM Form SCHEDULE 13G Korro Bio Ops, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 5, 2026 07:03AM Cellectar Biosciences raises up to $140 million in oversubscribed financing
Apr 27, 2026 07:15AM Sagimet prices $175 million stock offering at $6 per share
Apr 16, 2026 07:00AM Adlai Nortye raises $150 million in private placement financing
View Older Stories